US Critical Metals Corp
USCM
Mydecine Innovations Group Inc
MYCO
Three Valley Copper Corp
TVC.H
Tuga Innovations Inc
TUGA
Windfall Geotek Inc
WIN
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 49.43%2.6M | 206.48%3.9M | -55.66%652.96K | -44.38%6.48M | 119.51%2M | -44.25%1.74M | -65.28%1.27M | -62.88%1.47M | 44.77%11.66M | -84.16%912.29K |
Net income from continuing operations | -9.18%1.1M | 388.15%1.92M | -18.26%465.89K | -214.23%-5.37M | -279.70%-7.55M | 194.95%1.21M | -85.72%394.31K | -83.81%569.98K | -47.40%4.71M | -130.91%-1.99M |
Operating gains losses | ---- | ---- | ---- | ---18.28K | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization | 25.15%1.48M | 95.91%1.88M | 9.36%962.68K | 33.04%5.36M | 21.98%2.33M | 90.51%1.18M | 30.52%961.33K | 16.40%880.27K | 68.19%4.03M | 110.93%1.91M |
Asset impairment expenditure | ---- | ---- | ---- | 301.97%6.65M | ---- | ---- | ---- | ---- | 188.43%1.66M | ---- |
Deferred tax | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Other non cashItems | 135.43%42.68K | 9.47%19.82K | -101.32%-257 | -3,637.94%-860.78K | -1,702.80%-777.84K | -537.98%-120.46K | 62.20%18.11K | -32.64%19.41K | 190.09%24.33K | -123.46%-43.15K |
Change In working capital | 95.63%-23.29K | 166.30%67.98K | -25,538.12%-775.35K | -91.25%109.08K | 218.64%741.77K | -125.90%-533.2K | -167.48%-102.54K | 100.90%3.05K | 189.79%1.25M | -286.14%-625.22K |
-Change in receivables | -127.02%-35.65K | 120.26%216.48K | -230.89%-728.05K | -113.10%-48.71K | 143.73%331.59K | -70.95%131.93K | -562.83%-1.07M | 223.82%556.24K | 127.75%371.87K | -79.21%136.05K |
-Change in prepaid assets | 1,680.62%245.76K | -680.96%-168.45K | -35.23%-15.46K | -202.51%-151.66K | -363.81%-183.02K | -96.57%13.8K | 106.15%29K | 77.66%-11.44K | -418.50%-50.14K | 163.05%69.38K |
-Change in payables and accrued expense | 65.62%-233.4K | -97.87%19.95K | 94.12%-31.84K | -66.54%309.44K | 171.41%593.2K | -156.52%-678.93K | 138.79%936.93K | -434.77%-541.76K | 1,543.85%924.81K | -140.88%-830.65K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 49.43%2.6M | 206.48%3.9M | -55.66%652.96K | -49.69%5.86M | 51.67%1.38M | -44.25%1.74M | -65.28%1.27M | -62.88%1.47M | 44.77%11.66M | -84.16%912.29K |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -7,153.73%-7.79M | -134.33%-1.25M | 122.49%755.93K | -16.11%-14.94M | -1,032.47%-15.34M | 102.78%110.39K | 178.87%3.64M | -15.05%-3.36M | -344.31%-12.87M | -55.22%-1.35M |
Capital expenditure reported | -42,043.11%-10.27M | -4,464.63%-2.63M | -2,044.03%-2.12M | -82.09%-11.93M | -1,003.74%-11.74M | 99.50%-24.36K | 89.74%-57.61K | -22.62%-99K | -100.54%-6.55M | -465.75%-1.06M |
Net PPE purchase and sale | ---- | ---- | ---- | --210.55K | ---- | ---- | ---- | ---- | --0 | ---- |
Net investment purchase and sale | --0 | --0 | 488.89%7M | -226.02%-5.2M | -402.33%-7M | --0 | 310.48%3.6M | 28.00%-1.8M | -497.42%-1.59M | 22,242.81%2.32M |
Net other investing changes | 1,740.10%2.48M | 139.41%1.38M | -292.78%-4.12M | 141.67%1.97M | 222.61%3.19M | -76.32%134.75K | -48.85%-3.5M | 727.51%2.14M | -14,480.85%-4.73M | -274.98%-2.61M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -7,153.73%-7.79M | -2,890.95%-1.25M | 216.51%755.93K | -16.11%-14.94M | -1,032.47%-15.34M | 102.78%110.39K | 100.97%44.83K | 108.18%238.83K | -344.31%-12.87M | -55.22%-1.35M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 40,000.00%5.99M | 0.00%-15K | 0.00%-15K | 16,852.38%8.9M | 9,074.36%8.95M | 0.00%-15K | 0.00%-15K | 0.00%-15K | 101.38%52.5K | 102.56%97.5K |
Net issuance payments of debt | 40,000.00%5.99M | 0.00%-15K | 0.00%-15K | 14,933.33%8.9M | 59,733.33%8.95M | 0.00%-15K | 0.00%-15K | 0.00%-15K | 98.42%-60K | 99.61%-15K |
Net common stock issuance | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --112.5K | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 40,000.00%5.99M | 0.00%-15K | 0.00%-15K | 16,852.38%8.9M | 9,074.36%8.95M | 0.00%-15K | 0.00%-15K | 0.00%-15K | 101.38%52.5K | 102.56%97.5K |
Net cash flow | ||||||||||
Beginning cash position | 25.69%4.14M | -24.24%1.51M | -61.05%114.98K | -79.74%295.2K | 700.97%5.13M | 117.63%3.29M | -19.94%1.99M | -79.74%295.2K | 1,260.21%1.46M | 66.64%639.87K |
Current changes in cash | -56.67%794.02K | 102.13%2.63M | -17.84%1.39M | 84.49%-180.22K | -1,353.61%-5.01M | 309.87%1.83M | 233.46%1.3M | 64.55%1.7M | -186.06%-1.16M | -132.13%-344.67K |
End cash Position | -3.76%4.93M | 25.69%4.14M | -24.24%1.51M | -61.05%114.98K | -61.05%114.98K | 700.97%5.13M | 117.63%3.29M | -19.94%1.99M | -79.74%295.2K | -79.74%295.2K |
Free cash from | -547.87%-7.67M | 4.34%1.27M | -206.99%-1.47M | -218.65%-6.06M | -6,726.88%-10.36M | 199.16%1.71M | -60.85%1.21M | -64.66%1.37M | 6.72%5.11M | -102.72%-151.76K |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.